JIA Qiu-lei,XIAO Xiang,HU Yuan-hui,et al.Study on TCM syndrome characteristics in coronary artery disease patients with persistent atrial fibrillation[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1091-1095.
JIA Qiu-lei,XIAO Xiang,HU Yuan-hui,et al.Study on TCM syndrome characteristics in coronary artery disease patients with persistent atrial fibrillation[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1091-1095. DOI: 10.16025/j.1674-1307.2022.10.004.
Study on TCM syndrome characteristics in coronary artery disease patients with persistent atrial fibrillation
Objective,2,To summarize TCM syndrome characteristics of coronary artery disease (CAD) patients accompanied with persistent atrial fibrillation (PeAF).,Methods,2,A total of 282 CAD patients with PeAF were selected and the symptoms and signs of these patients were collected by four diagnostic methods, then TCM syndromes were performed cluster analysis.,Results,2,Chest tightness, palpitation, insomnia and fatigue were the most common symptoms of CAD accompanied with PeAF, dark red tongue and yellow greasy tongue were common tongue manifestations, and thin wiry pulse and wiry smooth pulse are common pulse conditions. There were four common TCM syndromes, that is Qi and Yin deficiency syndrome complicated with phlegm and blood stasis, deficiency of liver and kidney, Yin deficiency and fire flourishing syndrome, blood stasis and water retention syndrome.,Conclusion,2,The main TCM syndrome of CAD patients with PeAF is Qi and Yin deficiency together with phlegm and blood stasis. To some extent, the research results could reflect the clinical syndrome distribution characteristics of CAD accompanied with PeAF, which is helpful to guide the clinical syndrome differentiation and treatment.
PADFIELD GJ, STEINBERG C, SWAMPILLAI J, et al. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian registry of atrial fibrillation[J]. Heart Rhythm, 2017,14(6):801-807.
YANG WY, DU X, FAWZY AM, et al. Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the chinese atrial fibrillation registry study[J]. J Cardiovasc Electrophysiol, 2021,32(2):333-341.
KANNEL WB, ABBOTT RD, SAVAGE DD, et al. Coronary heart disease and atrialfibrillation: the framingham study[J]. Am Heart J,1983,106(2):389-396.
ARONOW WS, AHN C, MERCANDO AD, et al. Correlation of atrial fibrillation, paroxysmal supraventricular tachycardia, and sinus rhythm with incidences of new coronary events in 1,359 patients, mean age 81 years, with heart disease[J]. Am J Cardiol,1995,75(2):182-184.
HU WS, LIN CL. Impact of atrial fibrillation on stroke, heart failure, and mortality in diabetic patients with coronary artery disease[J]. J Diabetes Complications, 2021,35(1):107762.
KIRCHHOF P, BENUSSI S, KOTECHA D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962.
LAU DH, NATTEL S, KALMAN JM, et al. Modifiable risk factors and atrial fibrillation[J]. Circulation,2017,136(6):583-596.
SCHNOHR P, MAROTT JL, KRISTENSEN TS, et al. Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study[J]. Eur Heart J,2015,36(22):1385-1393.